China expands drug bulk-buy programme, puts pressure on pharma firms
The programme, rolled out last year, saw 11 Chinese cities, including Beijing and Shanghai, band together behind a tender process…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Novartis
Novartis’s Sandoz licenses proposed multiple sclerosis biosimilar
The medicine is in Phase III clinical development for the treatment of relapsing-remitting multiple sclerosis (RRMS)
Big Pharma to get bigger, but what about patients?
The second patent cliff is around the corner, as patents for branded molecules with cumulative global sales of over $ 251 billion…
Novartis continues to build healthcare talent ecosystem, announces BioCamp 2019
BioCamp engages students around scientific advances to address unmet medical needs and entrepreneurial opportunities and offers 50…
Novartis announces 26 week gender-neutral parental leave
The company will also offer coaching to associates going on leave for a seamless reintegration into the workplace when they resume…
US group says Novartis MS drug price out of line with benefit
The Boston-based Institute for Clinical and Economic Review (ICER), which has been reviewing Mayzent for months, recommended that…
Novartis splits drugs business into two
David Epstein, Division Head and Chief Executive, Novartis Pharmaceuticals to leave the company
Novartis is splitting its…
Novartis’ Afinitor reduces seizures in patients with tuberous sclerosis complex
Results presented at American Academy of Neurology will be discussed with health authorities for potential worldwide regulatory…
Sun Pharma enters Japanese prescription market
Acquires 14 prescription brands
Sun Pharma has acquired 14 established prescription brands from Novartis in Japan. According to…
Aurobindo Pharma receives US FDA approval for rivastigmine tartrate capsules
The product is expected to be launched in Q1 FY16-17